14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Mar 01, 2024 Buy 33 496 Woodworth Marshall H Common Stock
Dec 01, 2023 Buy 7 157 Tursi James Patrick Common Stock
Dec 01, 2023 Buy 25 000 Tursi James Patrick Common Stock
Nov 01, 2023 Buy 0 Tursi James Patrick
Oct 27, 2023 Buy 0 Woodworth Marshall H
Aug 11, 2023 Buy 625 064 Kim Hyung Heon Common Stock
Jul 27, 2023 Buy 12 500 Koven Andrew I Common Stock
Jul 27, 2023 Buy 87 500 Koven Andrew I Common Stock
Jul 27, 2023 Buy 12 500 Salsbury Michael Common Stock
Jul 27, 2023 Buy 87 500 Salsbury Michael Common Stock
Jul 27, 2023 Buy 12 500 Strickland D Gordon Common Stock
Jul 27, 2023 Buy 87 500 Strickland D Gordon Common Stock
Jul 27, 2023 Buy 12 500 Groves Jason L Common Stock
Jul 27, 2023 Buy 87 500 Groves Jason L Common Stock
Jul 27, 2023 Buy 12 500 Glickman Mark A Common Stock
Jul 27, 2023 Buy 25 000 Glickman Mark A Common Stock
Jul 27, 2023 Buy 12 500 Kim Na Yeon Common Stock
Jul 27, 2023 Buy 87 500 Kim Na Yeon Common Stock
May 11, 2023 Buy 0 Glickman Mark A
Jan 12, 2023 Buy 0 Hooker Joseph
Jan 12, 2023 Buy 0 Hooker Joseph
Nov 16, 2022 Buy 0 Goldman Sachs Group Inc Common Stock
Jul 26, 2022 Buy 4 671 Kim Na Yeon Common Stock
Jul 26, 2022 Sell 1 445 267 E&healthcare Investment Fund Ii Common Stock
Jul 26, 2022 Sell 1 445 267 Kim Na Yeon Common Stock
Jun 09, 2022 Buy 20 000 Kim Na Yeon Nonstatutory Stock Option (right to buy)
Jun 09, 2022 Buy 20 000 Groves Jason L Nonstatutory Stock Option (right to buy)
Jun 09, 2022 Buy 20 000 Groves Jason L Nonstatutory Stock Option (right to buy)
Jun 09, 2022 Buy 20 000 Kim Hyung Heon Nonstatutory Stock Option (right to buy)
Jun 09, 2022 Buy 20 000 Kang Richard Nonstatutory Stock Option (right to buy)
Jun 09, 2022 Buy 20 000 Strickland D Gordon Nonstatutory Stock Option (right to buy)
Jun 09, 2022 Buy 20 000 Salsbury Michael Nonstatutory Stock Option (right to buy)
Jun 09, 2022 Buy 20 000 Salsbury Michael Nonstatutory Stock Option (right to buy)
Jun 09, 2022 Buy 20 000 Koven Andrew I Nonstatutory Stock Option (right to buy)
Jun 09, 2022 Buy 20 000 Koven Andrew I Nonstatutory Stock Option (right to buy)
Jan 27, 2022 Buy 40 000 Strickland D Gordon Non-qualified Stock Option (right to buy)
Jan 27, 2022 Buy 0 Strickland D Gordon
Nov 03, 2021 Buy 616 666 Price Ben Gil Nonstatutory Stock Option (right to buy)
Nov 03, 2021 Buy 0 Price Ben Gil
Sep 02, 2021 Buy 60 000 Koven Andrew I Nonstatutory Stock Option (right to buy)
Jul 09, 2021 Buy 0 Kim Hyung Heon
Jul 09, 2021 Buy 0 Koven Andrew I
Dec 31, 2020 Buy 855 059 Bakshi Akash Common Stock
Dec 31, 2020 Buy 29 013 Bakshi Akash Common Stock
Dec 31, 2020 Buy 0 Bakshi Akash
Sep 01, 2020 Buy 60 000 Swirsky Douglas J Non-qualified stock option (right to buy)
Sep 01, 2020 Buy 0 Swirsky Douglas J
Jan 13, 2020 Buy 60 000 Salsbury Michael Non-qualified stock option (right to buy)
Jan 13, 2020 Buy 60 000 Oh Jeong Gyun Non-qualified stock option (right to buy)
Jan 13, 2020 Buy 60 000 Kim Na Yeon Non-qualified stock option (right to buy)
Jan 13, 2020 Buy 60 000 Jeong Tae Heum Non-qualified stock option (right to buy)
Jan 13, 2020 Buy 60 000 Gullans Steven R. Ph.d. Non-qualified stock option (right to buy)
Jan 13, 2020 Buy 60 000 Groves Jason L Non-qualified stock option (right to buy)
Dec 30, 2019 Sell 0 Jk Biopharma Solutions, Inc Common Stock
Dec 30, 2019 Sell 0 Jk Biopharma Solutions, Inc Common Stock
Dec 30, 2019 Buy 0 E&investment, Inc. Common Stock
Dec 30, 2019 Buy 0 E&investment, Inc. Common Stock
Dec 30, 2019 Buy 0 E&investment, Inc. Common Stock
Dec 30, 2019 Buy 0 Jk Biopharma Solutions, Inc Common Stock
Dec 30, 2019 Buy 0 Jk Biopharma Solutions, Inc Common Stock
Dec 30, 2019 Buy 0 E&investment, Inc. Common Stock
Dec 30, 2019 Buy 0 E&investment, Inc. Common Stock
Dec 30, 2019 Buy 0 E&investment, Inc. Common Stock
Dec 30, 2019 Buy 0 Dong-a St Co., Ltd Common Stock
Dec 30, 2019 Buy 297 206 Versavel Mark Stock Option (right to buy)
Dec 30, 2019 Buy 45 724 Versavel Mark Stock Option (right to buy)
Dec 30, 2019 Buy 1 817 842 Oh Jeong Gyun Common Stock
Dec 30, 2019 Buy 240 051 Oh Jeong Gyun Common Stock
Dec 30, 2019 Buy 4 335 800 Kim Na Yeon Common Stock
Dec 30, 2019 Buy 1 864 799 Kim Na Yeon Common Stock
Dec 30, 2019 Buy 1 121 190 Kim Na Yeon Common Stock
Dec 30, 2019 Buy 0 Oh Jeong Gyun
Dec 30, 2019 Buy 0 Kim Na Yeon
Dec 30, 2019 Buy 0 Kang Jeong Gu
Dec 30, 2019 Buy 0 Shannon Nicola
Dec 30, 2019 Buy 0 Versavel Mark
Dec 30, 2019 Buy 0 Salsbury Michael
Dec 30, 2019 Buy 0 Groves Jason L
Dec 30, 2019 Buy 0 Jeong Tae Heum
Jul 24, 2019 Buy 15 000 Sassine Andy Common Stock
Jul 24, 2019 Buy 15 000 Lichtinger Pedro Common Stock
Jul 24, 2019 Buy 15 000 Kousky Kenneth W Common Stock
Jul 24, 2019 Buy 100 000 Reno Seth Common Stock
Jul 24, 2019 Buy 100 000 Bisgaier Charles Phd Common Stock
Jul 24, 2019 Buy 300 000 Gullans Steven R. Ph.d. Common Stock
May 22, 2018 Buy 50 000 Gullans Steven R. Ph.d. Employee Stock Option (right to buy)
May 01, 2018 Buy 150 000 Gullans Steven R. Ph.d. Employee Stock Option (right to buy)
Feb 08, 2018 Buy 14 286 Reno Seth Common Stock
Feb 08, 2018 Buy 71 429 Gullans Steven R. Ph.d. Common Stock
Jan 29, 2018 Buy 10 800 Sassine Andy Stock Option (right to buy)
Jan 29, 2018 Buy 10 800 Lichtinger Pedro Stock Option(right to buy)
Jan 29, 2018 Buy 10 800 Kousky Kenneth W Stock Option (right to buy)
Jan 29, 2018 Buy 10 800 Hawryluk P. Kent Stock Option (right to buy)
Jan 29, 2018 Buy 60 000 Gullans Steven R. Ph.d. Employee Stock Option (right to buy)
Jan 28, 2018 Buy 48 000 Bisgaier Charles Phd Stock Option (right to buy)
Jan 28, 2018 Buy 148 000 Golden Lee Scott Employee Stock Option (right to buy)
Jan 28, 2018 Buy 48 000 Mathiesen Jeffrey S Employee Stock Option (right to buy)
Jan 28, 2018 Buy 48 000 Reno Seth Employee Stock Option (right to buy)
Aug 14, 2017 Buy 3 207 Mathiesen Jeffrey S Common Stock
Aug 14, 2017 Sell 3 207 Mathiesen Jeffrey S Employee Stock Option (right to buy)
INSIDER POWER
32.437
Last 100 transactions
Buy: 14 405 360 | Sell: 2 893 741 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 32.437.

In total, the insiders bought 14 405 360 and sold 2 893 741 NRBO shares in the last 100 trades.

Click to get the best stock tips daily for free!

About NeuroBo Pharmaceuticals, Inc.

NeuroBo Pharmaceuticals. NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat the symptoms of cognitive impairment and modify ... NRBO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT